Argent Advisors’s Avanos Medical AVNS Stock Holding History

Argent Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3	Closed	–	–	151
2019 Q4	$0	Buy	+3	New	+$109	﹤0.01%	493

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Argent Advisors's AVNS Position: Q1 2020 in Review

Argent Advisors sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 3 shares.

Argent Advisors first reported a position in AVNS in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

Argent Advisors reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
Argent Advisors sold 3 Avanos Medical shares in Q1 2020.
Argent Advisors first reported a position in Avanos Medical in Q4 2019 and held it in 1 quarter.
Argent Advisors's Avanos Medical position peaked at $0 in Q4 2019.
272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Argent Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.